| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.7451 | 
      | Human Intestinal Absorption | HIA+ | 0.9971 | 
      | Caco-2 Permeability | Caco2+ | 0.9199 | 
      | P-glycoprotein Substrate | Non-substrate | 0.6264 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.7625 | 
                                                     | Non-inhibitor | 0.8157 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8949 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8861 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7572 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8288 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5905 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.5704 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9550 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9267 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.6309 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8021 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6804 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9675 | 
                                                                    | Non-inhibitor | 0.9396 | 
      | AMES Toxicity | Non AMES toxic | 0.8820 | 
      | Carcinogens | Non-carcinogens | 0.8599 | 
      | Fish Toxicity | High FHMT | 0.8808 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9784 | 
      | Honey Bee Toxicity | High HBT | 0.8193 | 
      | Biodegradation | Not ready biodegradable | 0.5324 | 
      | Acute Oral Toxicity | III | 0.8684 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5972 |